Seeing Is Believing
Currently out of the existing stock ratings of Sarah James, 77 are a HOLD (22.85%), 248 are a BUY (73.59%), 12 are a SELL (3.56%).
Analyst Sarah James, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 57.98% that have a potential upside of 24.72% achieved within 217 days.
Sarah James’s has documented 663 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HUM, Humana at 30-Apr-2025.
Analyst best performing recommendations are on CYH (COMMUNITY HEALTH SYSTEMS).
The best stock recommendation documented was for LFMD (LIFEMD) at 3/12/2024. The price target of $11 was fulfilled within 8 days with a profit of $2.62 (31.26%) receiving and performance score of 39.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$61
$-1.79 (-2.85%)
$64
15 days ago
(29-Apr-2025)
12/26 (46.15%)
$1.74 (2.94%)
149
Buy
$84
$21.21 (33.78%)
$93
16 days ago
(28-Apr-2025)
0/6 (0%)
$24.53 (41.25%)
Buy
$85
$22.21 (35.37%)
$95
5 months 1 days ago
(12-Dec-2024)
13/19 (68.42%)
$25.58 (43.05%)
301
Buy
$84
$21.21 (33.78%)
$89
5 months 1 days ago
(12-Dec-2024)
0/4 (0%)
$24.58 (41.37%)
Buy
$80
$17.21 (27.41%)
$104
5 months 1 days ago
(12-Dec-2024)
4/6 (66.67%)
$20.58 (34.63%)
110
Which stock is Sarah James is most bullish on?
Which stock is Sarah James is most reserved on?
What Year was the first public recommendation made by Sarah James?